EXCELLENCE CENTER FOR DERMATOLOGY R&D

site icon

Who We Are

Maruho Israel Innovation Labs (MII LABS), a wholly owned subsidiary of MII Fund, is a full-service dermatology CRO.

Operating from state-of-the-art facility in Rehovot, MII labs provides the entire range of services required for topical drug development from concept to clinical proof.

MII Labs is a one-stop solution for companies, entrepreneurs, or scientists, who wish to achieve the most comprehensive and efficient R&D program for developing their innovative pharmaceuticals for dermatological or cosmetic applications.

site icon

Our Expertise

MII Labs has expertise working with a range of Active Pharmaceutical Ingredient (APIs) including poorly soluble compounds, New Chemical Entities (NCEs), small and large molecules, pro-drugs, and high potency compounds.

From development plan creation to reproducible and scalable formulations that meet regulation requirements. We customize each development path to meet your needs in the fastest and most efficient route.

red dots

Our Services

beaker

Formulation Development

skin-cells

Clinical services

statistics

Analytical Services

skin

Pre-Clinical Services

Our Team

The scientists in MII labs are highly skilled professionals with expertise and vast experience in topical/transdermal skin delivery, formulation development, biology and pharmaceutical sciences, QA and regulation

Inbal Ziv

CEO

Dr. Tal Berman

CTO

Limor Regev Yuzik

CFO

Dr. Sharon Perles

Clinical Manager

Nir Rapaport

Formulation scientist

Daria Lisovets

Analytical Supervisor

Inna Ziglboim

Director of Administration

OUR FACILITY

312 sq.m. located in Rehovot, Israel

State-of-the-art laboratories

Specifically designed and equipped to address any need along the dermatological R&D path, from the pre-clinical stages through the clinical proof of concept

2 Formulation Labs &
1 Analytical Lab